Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

The pathogenesis of atherosclerosis: a perspective for the 1990s

Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618 · see citing works

Beyond Cholesterol

Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425 · see citing works

Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.

Ku, D. N., Giddens, D. P., Zarins, C. K., & Glagov, S. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.3.293 · Cited by 2,714 · see citing works

Role of oxidized low density lipoprotein in atherogenesis.

Witztum, J. L., & Steinberg, D. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,682 · see citing works

Atherosclerosis: Basic Mechanisms

Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,726 · see citing works

Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress.

Zarins, C. K., Giddens, D. P., Bharadvaj, B. K., Sottiurai, V. S., Mabon, R. F., & Glagov, S. (1983) · Circulation Research · doi:10.1161/01.res.53.4.502 · Cited by 1,486 · see citing works

The oxidation hypothesis of atherosclerosis

Witztum, J. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92346-9 · Cited by 1,394 · see citing works

Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries.

Glagov, S., Zarins, C. K., Giddens, D. P., & Ku, D. N. (1988) · PubMed · Cited by 1,029 · see citing works

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Ylä‐Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 871 · see citing works

Changing concepts of atherogenesis

Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 629 · see citing works

Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion

Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611 · see citing works

Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.

Rollins, B. J., Yoshimura, T., Leonard, E. J., & Pober, J. S. (1990) · Europe PMC (PubMed Central) · Cited by 492 · see citing works

Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes

Hyka, N., Dayer, J., Modoux, C., Kohno, T., Edwards, C. K., Roux‐Lombard, P., & Burger, D. (2001) · Blood · doi:10.1182/blood.v97.8.2381 · Cited by 388 · see citing works

Adhesion molecules and atherogenesis

Huo, Y., & Ley, K. F. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00882.x · Cited by 335 · see citing works

Direct Demonstration of P-Selectin– and VCAM-1–Dependent Mononuclear Cell Rolling in Early Atherosclerotic Lesions of Apolipoprotein E–Deficient Mice

Ramos, C. L., Huo, Y., Jung, U., Ghosh, S., Manka, D. R., Sarembock, I. J., & Ley, K. F. (1999) · Circulation Research · doi:10.1161/01.res.84.11.1237 · Cited by 272 · see citing works

Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis

Gawaz, M., Brand, K., Dickfeld, T. L., Pogátsa-Murray, G., Page, S., Bogner, C., Koch, W., Schömig, A., & Neumann, F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00241-5 · Cited by 254 · see citing works

Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions

Huo, Y., Hafezi‐Moghadam, A., & Ley, K. F. (2000) · Circulation Research · doi:10.1161/01.res.87.2.153 · Cited by 233 · see citing works

Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells.

Rollins, B. J., & Pober, J. S. (1991) · PubMed · Cited by 157 · see citing works

Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size

Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147 · see citing works

Local Overexpression of Monocyte Chemoattractant Protein-1 at Vessel Wall Induces Infiltration of Macrophages and Formation of Atherosclerotic Lesion

Namiki, M., Kawashima, S., Yamashita, T., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.102278 · Cited by 144 · see citing works

Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction

Keaney, J. F. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00005-4 · Cited by 123 · see citing works

Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice

Peters, W., & Charo, I. F. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00011 · Cited by 122 · see citing works

Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1.

Valente, A. J., Rozek, M. M., Sprague, E. A., et al. (1992) · PubMed · Cited by 72 · see citing works

Interleukin-1β Inhibits Expression of p21(WAF1/CIP1) and p27(KIP1) and Enhances Proliferation in Response to Platelet-Derived Growth Factor-BB in Smooth Muscle Cells

Nathe, T., Deou, J., Walsh, B., Bourns, B. D., Clowes, A. W., & Daum, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023428.69244.49 · Cited by 43 · see citing works

IL-1β AND TNF-α SUPPRESS APOLIPOPROTEIN (APO) E SECRETION AND APO A-I EXPRESSION IN HepG2 CELLS

Song, H., Saito, K., Fujigaki, S., et al. (1998) · Cytokine · doi:10.1006/cyto.1997.0291 · Cited by 38 · see citing works

Activated platelets induce secretion of interleukin-1β, monocyte chemotactic protein-1, and macrophage inflammatory protein-1α and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells

Kwab, J., Jeong, M. H., Bae, H. R., et al. (2000) · Journal of Korean Medical Science · doi:10.3346/jkms.2000.15.3.273 · Cited by 38 · see citing works

Adhesion of Monocyte Very Late Antigen-4 to Endothelial Vascular Cell Adhesion Molecule-1 Induces Interleukin-1β–Dependent Expression of Interleukin-6 in Endothelial Cells

Zohlnhöfer, D., Brand, K., Schipek, K., Pogátsa-Murray, G., Schömig, A., & Neumann, F. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.353 · Cited by 37 · see citing works

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482 · see citing works

Inflammasomes: mechanism of action, role in disease, and therapeutics

Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · see citing works

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618 · see citing works

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · see citing works

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536 · see citing works

Macrophage Phenotype and Function in Different Stages of Atherosclerosis

Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121 · see citing works

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039 · see citing works

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019 · see citing works

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002 · see citing works

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926 · see citing works

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799 · see citing works

<i>Akkermansia Muciniphila</i> Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in <i>Apoe</i> ^−/− Mice

Li, J., Lin, S., Vanhoutte, P. M., Woo, C. W., & Xu, A. (2016) · Circulation · doi:10.1161/circulationaha.115.019645 · Cited by 775 · see citing works

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634 · see citing works

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

Bertheloot, D., & Latz, E. (2017) · Cellular &amp; Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455 · see citing works

Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Koushki, K., Shahbaz, S. K., Mashayekhi, K., Sadeghi, M., Zayeri, Z. D., Taba, M. Y., Banach, M., Al-Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Clinical Reviews in Allergy &amp; Immunology · doi:10.1007/s12016-020-08791-9 · Cited by 382 · see citing works

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report

van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348 · see citing works

Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity

Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338 · see citing works

Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis

Westerterp, M., Fotakis, P., Ouimet, M., Bochem, A. E., Zhang, H., Molusky, M. M., Wang, W., Abramowicz, S., la Bastide-van Gemert, S., Wang, N., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032636 · Cited by 331 · see citing works

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy

Koenig, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.113 · Cited by 315 · see citing works

Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis

Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300 · see citing works

AMPK, Mitochondrial Function, and Cardiovascular Disease

Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286 · see citing works

Cytokines and abnormal glucose and lipid metabolism

Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282 · see citing works

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260 · see citing works

Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility

Xiao, H., Lu, M., Lin, T. Y., Chen, Z., Chen, G., Wang, W.-C., Marin, T., Shentu, T.-P., Wen, L., Gongol, B., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002714 · Cited by 257 · see citing works

Vascular Smooth Muscle Cell Apoptosis Induces Interleukin-1–Directed Inflammation: Effects of Hyperlipidemia-Mediated Inhibition of Phagocytosis

Clarke, M. C. H., Talib, S., Figg, N. L., & Bennett, M. R. (2010) · Circulation Research · doi:10.1161/circresaha.109.208389 · Cited by 216 · see citing works

The arterial microenvironment: the where and why of atherosclerosis

Yurdagul, A., Finney, A. C., Woolard, M. D., & Orr, A. W. (2016) · Biochemical Journal · doi:10.1042/bj20150844 · Cited by 185 · see citing works

The Inflammasome in Atherosclerosis and Type 2 Diabetes

Masters, S. L., Latz, E., & O’Neill, L. A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001902 · Cited by 169 · see citing works

Multiple aberrations in shared inflammatory and oxidative &amp; nitrosative stress (IO&amp;NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169 · see citing works

Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?

Welsh, P., Grassia, G., Botha, S., Sattar, N., & Maffia, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13818 · Cited by 164 · see citing works

Inflammasomes: sensors of metabolic stresses for vascular inflammation

Yang, X.-F. (2013) · Frontiers in Bioscience · doi:10.2741/4127 · Cited by 134 · see citing works

Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review

Navarese, E. P., Kołodziejczak, M., Kereiakes, D. J., Tantry, U. S., O'Connor, C., & Gurbel, P. A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2994 · Cited by 77 · see citing works

p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis

Rajamäki, K., Mäyränpää, M. I., Risco, A., Tuimala, J., Nurmi, K., Cuenda, A., Eklund, K. K., Öörni, K., & Kovanen, P. T. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307312 · Cited by 75 · see citing works

Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation

Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69 · see citing works

Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis

Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63 · see citing works

AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6

Gongol, B., Marin, T., Peng, I.-C., Woo, B., Martin, M., King, S., Sun, W., Johnson, D. A., Chien, S., & Shyy, J. Y.-J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222051110 · Cited by 61 · see citing works

LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells

Hwang, H.-J., Jung, T. W., Hong, H. C., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Choi, D. S., Baik, S. H., & Yoo, H. J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.001 · Cited by 60 · see citing works

TRα Protects Against Atherosclerosis in Male Mice: Identification of a Novel Anti-Inflammatory Property for TRα in Mice

Billon, C., Canaple, L., Fleury, S., Deloire, A., Beylot, M., Dombrowicz, D., del Carmine, P., Samarut, J., & Gauthier, K. (2014) · Endocrinology · doi:10.1210/en.2014-1098 · Cited by 45 · see citing works

Rôle de l’inflammasome dans les pathologies cardiovasculaires

Connat, J.-L. (2011) · Annales de Cardiologie et d'Angéiologie · doi:10.1016/j.ancard.2010.07.011 · Cited by 12 · see citing works

Direct Chemotaxis and Leucocyte‐Induced Chemotaxis of Polymorphonuclear Leucocytes

Bäck, O., Bandmann, U., Norberg, B., et al. (1978) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1978.tb02435.x · Cited by 15 · see citing works

NEUTROPHIL CELLULAR CHEMOTAXIS IN CHILDREN WITH DOWN'S SYNDROME

Humbert, J. R., Hambidge, K. M., Moore, L., et al. (1974) · Pediatric Research · doi:10.1203/00006450-197404000-00442

[Chemotaxis in normal and pathologic conditions].

Ermakova, N. G. (1983) · PubMed

Isolation ofCaenorhabditis elegansMutants Defective in Chemotaxis toward cAMP

Jeong, J., & Cho, N. J. (2006) · Integrative Biosciences · doi:10.1080/17386357.2006.9647308

Abnormalities of monocyte chemotaxis following thermal injury

Altman, L. C., Klebanoff, S. J., & Curreri, P. W. (1977) · Journal of Surgical Research · doi:10.1016/0022-4804(77)90099-3 · Cited by 2 · see citing works